JNJ
Johnson and Johnson $JNJ Not Moving. Kickback Schemes or Legitimate Marketing?: http://bit.ly/bpapAn
JNJ
Johnson and Johnson $JNJ Not Moving. Kickback Schemes or Legitimate Marketing?: http://bit.ly/dmAJOB
JNJ
Johnson and Johnson $JNJ Not Moving. With better handling Toyota can get its brand back on track: http://bit.ly/aI3ykw
JNJ
Johnson and Johnson $JNJ Not Moving. Kickback Schemes or Legitimate Marketing?: http://bit.ly/9eHyeE
JNJ
Congratulations to $JNJ CFO Dominic Caruso, voted as a 1st Place CFO by sell-side analystst - http://bit.ly/aUuhYU (via @irwebreport)
JNJ
Andrew Jones of E&Y points to $JNJ's Stelara & Allos' ($ALTH) Folotyn as 2009's novel drug approvals - Nature Reviews http://bit.ly/
JNJ
Thank heavens I didn't buy a Matrix in '08! Wow. It's no longer fair to compare $TM to $JNJ and Tylenol. This is a full-blown PR nightmare.
JNJ
Johnson and Johnson $JNJ Not Moving. ZACKS ANALYST BLOG HIGHLIGHTS: MASTERCARD INCORPORATED, BROA: http://bit.ly/cWdoq7
JNJ
Johnson and Johnson $JNJ Not Moving. Guvera Limited Launches Beta In Australia With Huge Success,: http://bit.ly/cEPf4n
JNJ
the Artificial Pancreas Project, $8 million partnership with Animas to develop a first-generation system http://bit.ly/94OirB $JNJ
JNJ
RT @jessefelder Toyota: How to Kill One of the Most Powerful Brands in the World http://bit.ly/deCgJ7 $TM $JNJ
JNJ
Toyota: How to Kill One of the Most Powerful Brands in the World http://bit.ly/deCgJ7 $TM $JNJ
JNJ
Stocks Going Ex Dividend 3rd Week of Feb http://bit.ly/9q9ASo $JNJ $BOH $HSY
JNJ
Johnson and Johnson $JNJ Not Moving. Market Focus with Tom Hudson: http://bit.ly/cr7w62
JNJ
Johnson and Johnson $JNJ Not Moving. Market Focus with Tom Hudson: http://bit.ly/9mz5eF
JNJ
.@mommadona My core Trading Portfolio consists of $MMM, $WAG, $TJX, $T, $CHD, $MCD, $JNJ, and $SYY and 14% cash. $$
JNJ
Johnson and Johnson $JNJ Dropped Over Half A Percent. Downturn presents new lease of life for Indian drug firms: http://bit.ly/dgLV52
JNJ
Johnson and Johnson $JNJ Dropped Over Half A Percent. Downturn presents new lease of life for Indian drug firms: http://bit.ly/9Jb4Ni
JNJ
Johnson and Johnson $JNJ Went Up Over 1%. Unilever, Diageo and J&J among winners in awards for new: http://bit.ly/bzJ6BB
JNJ
Unusual Movement: $DIS( Vol 38%,S1,R1,3dLow,2dHihg) $JNJ( Vol 59%,S1,R2,3dLow,2dHigh) $MMM( Vol 61%,S1,R1,3dLow,2dHigh)
JNJ
CAPS Members Bullish on $WU Also Bullish on $GE and $JNJ http://www.urltwit.com//nx
JNJ
CAPS Members Bullish on $WU Also Bullish on $GE and $JNJ http://www.urltwit.com//nx
JNJ
http://bit.ly/bH0rP6 $BSX $JNJ Boston Scientific to Pay $1.7 Billion to Settle Patent Suits
JNJ
$BSX v/s $JNJ - Huge Pay day for Johnson & Johnson! Boston Scientific to pay JNJ $1.73B in settlement - http://bit.ly/cujvL9 $$
JNJ
Johnson and Johnson $JNJ A Little Up. Watson inks generics deal with Indian pharma; J&J to get: http://bit.ly/aJolMV
JNJ
Johnson and Johnson $JNJ Now Trading. Boston Scientific Corporation (BSX) to Pay Johnson & Joh: http://bit.ly/brjYio
JNJ
Boston Sci Pays J&J $1.7B to End Stent Patent Dispute - Stocks To Watch Today - Barrons.com $BSX $JNJ http://bit.ly/cru4ee
JNJ
Reuters: Boston Scientific to pay J&J $1.73B to settle stent patent fights. $BSX $JNJ
JNJ
Albert-Culver Off on Q1 Revenue Miss - Stocks To Watch Today - Barrons.com $ACV $BARE $REV $JNJ $CL $PG http://bit.ly/bol8nE
Johnson & Johnson - JNJ Insiders
No Insiders
We have no insiders for Johnson & Johnson right now.
Know someone who is an insider on Johnson & Johnson?
Let us know.
Johnson & Johnson - JNJ information
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. Its Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional and over-the-counter pharmaceutical products under JOHNSON?S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, LISTERINE, REACH, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC names. The company?s Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology, and virology. Its products include REMICADE, a biologic to treat Crohn?s disease, ankylosing spondylitis, psoriasis, psoriatic arthritis, ulcerative colitis, and used to treat rheumatoid arthritis; TOPAMAX, for adjunctive and monotherapy use in epilepsy, as well as for treating migraines; PROCRIT that stimulates red blood cell production; RISPERDAL oral, a medication to treat the symptoms of schizophrenia, bipolar mania, and irritability associated with autistic behavior in indicated patients; RISPERDAL CONSTA, an injectable, and INVEGATM Extended-Release tablets to treat schizophrenia; LEVAQUIN and FLOXIN, anti-infective products; CONCERTA, a product for treating attention deficit hyperactivity disorder; ACIPHEX/PARIET, a proton pump inhibitor; and DURAGESIC/Fentanyl Transdermal, a treatment for chronic pain. Johnson & Johnson?s Medical Devices and Diagnostics segment offers circulatory disease management, orthopaedic joint reconstruction and spinal care and sports medicine, surgical care and women?s health, minimally invasive surgical, blood glucose monitoring and insulin delivery, and diagnostic products, as well as disposable contact lenses. The company was founded in 1886 and is based in New Brunswick, New Jersey....
www.jnj.com
115,500 Employees
Founded in 1886
JOHNSON & JOHNSON (JNJ:New York)
LAST $57.83 USD
CHANGE TODAY 0.00 0.00%
VOLUME 13.0M
As of 8:04 PM 07/29/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of JOHNSON & JOHNSON (JNJ)
|
OPEN
$58.10
|
PREVIOUS CLOSE
$57.83
|
|
|
DAY HIGH
$58.27
|
DAY LOW
$57.71
|
|
|
52 WEEK HIGH
04/20/10 - $66.20
|
52 WEEK LOW
07/22/10 - $56.86
|
|
|
MARKET CAP
159.5B
|
AVERAGE VOLUME 10 D
16.4M
|
|
|
EPS TTM
$4.72
|
SHARES OUTSTANDING
2.8B
|
|
|
EX-DATE
08/27/10
|
P/E TTM
12.3x
|
|
|
DIVIDEND
$2.16
|
DIVIDEND YIELD
3.48%
|
|
| K = Thousands M = Millions B = Billions | ||
related news
*Final Glance: Pharmaceuticals companies
AP Digital - 07/29/2010 6:03 PM ET
Final Glance: Medical Devices companies
AP Digital - 07/29/2010 6:03 PM ET
SD to get $155,000 in drug company settlement
AP Digital - 07/29/2010 2:18 PM ET
Midday Glance: Pharmaceuticals companies
AP Digital - 07/29/2010 1:49 PM ET
Midday Glance: Medical Devices companies
AP Digital - 07/29/2010 1:49 PM ET
Key developments for JOHNSON & JOHNSON (JNJ)
Johnson & Johnson expected to report Fiscal Year 2010 results on January 25, 2011. This event was calculated by Capital IQ (Created on July 25, 2010).
07/25/2010
Johnson & Johnson expected to report Fiscal Year 2010 results on January 25, 2011. This event was calculated by Capital IQ (Created on July 25, 2010).
Johnson & Johnson expected to report Q3 2010 results on October 19, 2010. This event was calculated by Capital IQ (Created on July 21, 2010).
07/21/2010
Johnson & Johnson expected to report Q3 2010 results on October 19, 2010. This event was calculated by Capital IQ (Created on July 21, 2010).
Johnson & Johnson Presents at BioNetwork West, Oct-25-2010 through Oct-27-2010
07/20/2010
Johnson & Johnson Presents at BioNetwork West, Oct-25-2010 through Oct-27-2010. Venue: Ritz Carlton Laguna Niguel, One Ritz Carlton Drive, Dana Point, CA 92629, United States. Presentation Date & Speakers: Oct-26-2010, Denise McGinn, Vice President of Licensing & New Business Development, Pharmaceuticals Group, Robert Wills, Vice President Alliance Management, Pharmaceuticals Group.
JNJ Competitors
| Company | Last | Change |
| Archer-Daniels-Midland Co | $27.00 USD | -0.66 |
| LG Electronics Inc | 100,500 KRW | 0.00 |
| Pfizer Inc | $15.09 USD | +0.09 |
| Toshiba Corp | ¥452.00 JPY | -10.00 |
| Unilever NV | €22.56 EUR | +0.045 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | JNJ | Industry Range |
| Price/Earnings | 11.9x |
|
| Price/Sales | 2.6x |
|
| Price/Book | 3.0x |
|
| Price/Cash Flow | 11.8x |
|
| TEV/Sales | 2.1x |
|
|
JNJ |
||
|
JNJ transactions
| Type Date |
Target |
|
Merger/Acquisition
July 11, 2010 |
Micrus Endovascular Corp. |
Johnson & Johnson - JNJ news
Wireless sensor watches blood sugar for diabetics
2010-07-29 03:12:52
Keywords: Health and medicine,Science; technology,Pharmaceuticals (sub-industry),Regulation and enforcement,United States of America,Washington / US Government News,Pharmaceuticals - diversified,Medical equipment - supplies and distribution,Industrial conglomerates
Quote: Read article
Rabbits grow their own joint replacements in study
2010-07-29 03:12:50
Keywords: Health and medicine,Science; technology,Pharmaceuticals (sub-industry),United States of America,Washington / US Government News,Australia,Asia,Medical equipment - supplies and distribution,Pharmaceuticals - diversified,General News,Nature Society and Scie
Quote: Read article
Why Novartis's Triaminic Giveaway Reminds Us of the Tour de France
2010-07-29 03:12:50
Quote: Read article
Genzyme Could Have Other Suitors: Report
2010-07-26 04:52:55
Keywords: Financial, News, Stock, Market, Headlines, Investments, Quotes, Trading, TheStreet.com, Joseph Woelfel ,Biotech
Quote: But the contact ended there and there hasn't been continuing dialogue after the casual expression of interest, these people said.Glaxo and and Johnson & Johnson declined to comment for the newspaper.Genzyme had $4.5 billion in sales last year. -- Written by Joseph Woelfel in New York. Stockpickr.com.......Read article
Lilly, Bristol withstand price pressures, forex
2010-07-23 08:51:56
Keywords: Pharmaceuticals (sub-industry),United States of America,Health and medicine,Biotechnology,Pharmaceuticals - diversified,General News,Nature Society and Science,Healthcare,Pharmaceuticals and biotechnology,Corporate Results,Major Breaking News,Business act
Quote: Read article
The Art of Balancing Budgets Without Raising Taxes
2010-07-23 08:51:54
Keywords: cory booker,new jersey,newark,toilet paper,state budget,debt,newark mayor,taxes,chris christie,adp,bristol myers squibb,campbell soup,honeywell,johnson and johnson,municipal workers,privatization,government waste,reason foundation,cost savings,,MARKE
Quote: Read article
New FDA report shows multiple lapses at J&J plant
2010-07-22 04:10:48
Keywords: New FDA report shows multiple lapses at J&J plant, jnj,mrk
Quote: (AP) -- A dozen recent federal inspections of a Johnson & Johnson factory for heartburn and other nonprescription medicines show a host of violations that could affect the quality and makeup of the drugs.A new report on inspections at the Lancaster, Pa., factory in the past month indicates a pattern of ignoring rules for manufacturing and quality, failure to investigate problems that could affect the composition of products, carelessness in cleaning and maintaining equipment, and shoddy record-k...Read article
Abbott 2Q profit edges past Wall Street estimates
2010-07-22 04:10:47
Keywords: Abbott 2Q profit edges past Wall Street estimates, abt,jnj, earnings
Quote: Some analysts question whether the Humira success story can hold up in the face of new competition from rival drugs made by Johnson & Johnson and Belgian drug maker UCB.But Leerink Swann analyst Rick Wise said the drug's better-than-expected performance suggests "Abbott's operational top-line growth story may still have legs.""International sales also outperformed, potentially suggesting a solid contribution from recently acquired Solvay," Wise added.Earlier this year Abbott completed a $6.6 bil...Read article
FDA slams another Johnson & Johnson plant
2010-07-22 04:10:46
Keywords: Johnson & Johnson, J&J, Johnson, Merck, tylenol, pepcid, mylanta, fda, food and drug administration, drugs, drug, lab, laboratory
Quote: Read article
UPDATE - New J&J plant woes include Pepcid flavor mixups
2010-07-22 04:10:44
Keywords: Pharmaceuticals - diversified,Pharmaceuticals (sub-industry),United States of America,Health and medicine,Washington / US Government News,Regulation and enforcement,Biotechnology,Healthcare,Pharmaceuticals and biotechnology,General News,Nature Society and
Quote: Read article
[$$] FDA Report Details JNJ's Quality Issues
2010-07-22 04:10:43
Quote: ROCKOFF New details emerged about quality-control issues at the third Johnson & Johnson plant to be cited by regulators in recent months. The Lancaster, Pa., plant, which makes heartburn medicines Pepcid and Mylanta, failed to look into consumers' complaints that various kinds of Pepcid tablets were mixed up in bottles, according to a Food and Drug Administration inspection report released Wednesday. Consumers had complained about finding mint and berry flavors or maximum and regular strength t...Read article
UPDATE - Stryker profit in line, but ortho sales weak
2010-07-21 09:38:37
Keywords: Corporate Results,Medical equipment - supplies and distribution,Pharmaceuticals (sub-industry),United States of America,Business activities,Healthcare,Healthcare services,Pharmaceuticals - diversified,Pharmaceuticals and biotechnology,Company News item,Ec
Quote: Read article
UPDATE - Reckitt agrees to buy condom firm SSL for $3.8 bln
2010-07-21 09:38:32
Keywords: United Kingdom,Western Europe,Europe,Household products,Personal products,Pharmaceuticals (sub-industry),Mergers and Acquisitions (including Changes of Ownership),Footwear,Corporate Results Forecasts,Hot stocks,Equities,Non cyclical consumer goods,Persona
Quote: Read article
Strong earnings from Apple send stock futures up
2010-07-21 09:38:31
Keywords: Strong earnings from Apple send stock futures up, aapl,jnj,ko,ms,wfc
Quote: Wells Fargo rose 5.4 percent in pre-opening trading, and Morgan Stanley rose 3.7 percent.The stronger results were a relief to investors who grew skittish over the past week because of weaker than expected revenues at companies including IBM and Johnson & Johnson. Investors have focused on revenue as companies report their financial results, believing that companies' sales are a good indicator of how the overall economy is doing. With the second-quarter earnings season now about halfway through,...Read article
Second J&J consumer drug plant under FDA scrutiny
2010-07-20 01:28:12
Keywords: Second J&J consumer drug plant under FDA scrutiny, jnj,mrk
Quote: (AP) -- A second Johnson & Johnson medicine factory is under scrutiny from federal regulators, while the company struggles to deal with bad publicity and repeated recalls at another factory.The healthcare giant in April shut down a plant in Fort Washington, a Philadelphia suburb, that's now linked to eight recalls of Tylenol and other nonprescription drugs for children and adults.Now the Food and Drug Administration has sent the company a critical report after a recent inspection found problems ...Read article
Former McKinsey & Company Chairman and Managing Director Ian Davis Appointed to Johnson & Johnson Board of Directors
2010-07-20 01:28:11
Keywords: Former McKinsey & Company Chairman and Managing Director Ian Davis Appointed to Johnson & Johnson Board of Directors, jnj
Quote: Weldon, chairman and chief executive officer of Johnson & Johnson. "He is a welcome addition to the board, and we look forward to working with him."In his more than 30 years at McKinsey, Davis has served as a consultant to a range of global organizations across the public, private and not-for-profit sectors. Prior to becoming Chairman and Managing Director, he was Managing Partner of McKinsey's practice in the United Kingdom and Ireland. His experience includes oversight for McKinsey clients and...Read article